TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07604974: A Study to Assess the Safety, Tolerability and Efficacy of ION775

Sponsor: Ionis Pharmaceuticals, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 72 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$1,992,000

Rescue Site Savings

+$1,328,000

Unlock Full NCT07604974 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07604974 Rescue Dossier →